Discontinued — last reported Q1 '22
Sales Rebates and Discounts
Merck & Co. Sales Rebates and Discounts decreased by 31.8% to $1.50B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 31.8%, from $2.20B to $1.50B. Over 5 years (FY 2020 to FY 2025), Sales Rebates and Discounts shows a downward trend with a -12.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase may signal higher competitive pressure or a shift in sales mix toward high-volume, lower-margin channels.
Detailed definition
This represents accrued liabilities for estimated rebates, volume discounts, and chargebacks owed to customers based on...
Peer comparison
Highly relevant for pharmaceutical and medical device companies; peers often disclose this as a significant deduction from gross sales.
sales_rebates_and_discountsHistorical Data
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $2.60B | $2.70B | $2.30B | $2.20B | $1.50B |
| QoQ Change | — | +3.8% | -14.8% | -4.3% | -31.8% |
| YoY Change | — | +3.8% | -14.8% | -4.3% | -31.8% |
Sales Rebates and Discounts at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s sales rebates and discounts?
- Merck & Co. (MRK) reported sales rebates and discounts of $1.50B in Q4 2025.
- How has Merck & Co.'s sales rebates and discounts changed year-over-year?
- Merck & Co.'s sales rebates and discounts decreased by 31.8% year-over-year, from $2.20B to $1.50B.
- What is the long-term trend for Merck & Co.'s sales rebates and discounts?
- Over 5 years (2020 to 2025), Merck & Co.'s sales rebates and discounts has grown at a -12.4% compound annual growth rate (CAGR), from $2.90B to $1.50B.
- What does sales rebates and discounts mean?
- Accrued costs for discounts and rebates promised to customers for their purchases.